Presentations, Posters & Abstracts
Investigators of the Add-Aspirin study regularly disseminate status updates and results from the study at conferences in the form of presentations and posters. Please find below a list of these presentations and posters.
- 2020: Embedding survivorship studies in an ongoing trial: Adding value to Add-Aspirin. UK Interdisciplinary Breast Cancer Symposium
- 2019: Use of an active run-in period in a cancer trial: The Add-Aspirin experience. International Clinical Trials Methodology Conference
- 2019: Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial. ASCO
- 2018: Aspirin use after radical cancer therapy – feasibility and toxicity data from the Add-Aspirin trial. NCRI Conference
- 2018: The Role of Aspirin Following Treatment for Early Stage Gastro-Oesophageal Cancer: Adherence and Tolerability Data from the Add-Aspirin Trial. AUGIS
- 2017: Co-enrolment of participants into multiple clinical trials: The Add-Aspirin trial experience. NCRI Conference
News and Resources
Contact Details
If you are an individual who is interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.
For healthcare professionals
Please log into the members area for Add-Aspirin contact details.
Register Interest
For healthcare professionals
If your centre would like to recruit participants to Add-Aspirin, contact us:
mrcctu.add-aspirin@ucl.ac.uk
From Monday 16th March 2020, to RANDOMISE a participant in the UK please call +44 (0)20 7670 4925, rather than the usual randomisation line.
To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.
We have been experiencing intermittent issues with the trial websites. In the event of an emergency unblinding outside of office hours (including over the Easter bank holidays), if the usual unblinding links are not working, please telephone +(0)20 7670 4906 or +(0)20 7670 4892 to reach one of the Trial Managers.
Unblind a participant in the UK